Want to see KMB full AI Analyst Report?
Top Page
Kimberly Clark
(NASDAQ:KMB)
Select Model
Select Model
Rating:60Neutral
Price Target:
$104.00
â–¼(-6.32% Downside)
Action:Reiterated
Date:10/13/26
KMB scores around the middle primarily due to a fundamentally profitable business with improving revenue trends and solid cash conversion, but constrained by elevated leverage and recent free-cash-flow weakness. Valuation helps via a strong dividend and reasonable P/E, while technicals and the latest call point to near-term headwinds and muted momentum.
Positive Factors
Sustained volume and mix momentum
Ten consecutive quarters of positive volume-plus-mix performance indicate sustained consumer demand and effective product execution. Continued momentum across major markets can support market-share resilience and provide a durable foundation for revenue growth beyond temporary pricing or promotional effects.
Negative Factors
Elevated leverage constrains financial flexibility
Debt-to-equity near 3.9x remains elevated despite improvement from prior years, leaving less flexibility if earnings or cash flow weaken. Meaningful leverage can constrain investment and acquisition capacity while increasing the importance of consistent operating performance and successful integration.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained volume and mix momentum
Ten consecutive quarters of positive volume-plus-mix performance indicate sustained consumer demand and effective product execution. Continued momentum across major markets can support market-share resilience and provide a durable foundation for revenue growth beyond temporary pricing or promotional effects.
Read all positive factors
Kimberly Clark Key Performance Indicators (KPIs)
Any
Operating Income by Segment
Shows profitability across different business segments, highlighting which areas are driving earnings and where there might be challenges or opportunities for improvement.
Shows profitability across different business segments, highlighting which areas are driving earnings and where there might be challenges or opportunities for improvement.
Data provided by:
The Fly
The FlyKimberly Clark (KMB) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$32.85B
Dividend Yield5.19%
Average Volume (3M)4.43M
Price to Earnings (P/E)16.7
Beta (1Y)0.18
Revenue Growth-12.19%
EPS Growth-19.22%
CountryUS
Employees36,000
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)5.88
Shares Outstanding332,579,040
10 Day Avg. Volume4,194,765
30 Day Avg. Volume4,434,357
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)22.37
Price to Sales (P/S)1.95
P/FCF Ratio20.50
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue2.55
Enterprise Value/Gross Profit6.96
Enterprise Value/Ebitda13.27
Forecast
1Y Price Target
$116.91Price Target Upside5.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)7.38
Revenue Forecast (FY)$16.60B
Kimberly Clark Business Overview & Revenue Model
Company Description
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposab...
How the Company Makes Money
Kimberly-Clark makes money primarily by selling branded and, in some markets, value-tier consumer hygiene and tissue products to retailers and distributors, who then sell to end consumers. The company’s core revenue streams come from (1) Personal ...
Kimberly Clark Earnings Call Summary
Earnings Call Date:Aug 04, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 27, 2026
Earnings Call Sentiment Neutral
The call balanced operational and strategic strengths against several meaningful near-term headwinds. Positives included sustained volume-plus-mix momentum (10 consecutive quarters), industry-leading productivity (6.4%), a $45M tariff refund that boosted Q2 operating profit and EPS, progress on Arbex and Kenvue integration, and a compelling innovation roadmap highlighted by an alternative natural fiber program. Offsetting those strengths were discrete and material challenges: a China diaper disruption (noted as significant and causing quarterly basis-point impacts), retailer destocking and an LA distribution-center fire that pressured North America shipments, a moderating category growth backdrop, elevated input-cost headwinds (~$150M in H2), and increased promotional/competitive intensity. Management expects to mitigate inflationary impacts and remains confident in long-term prospects, but near-term visibility (including 2027 cadence) is limited.Positive Updates
Sustained Volume + Mix Momentum
Delivered 10th consecutive quarter of positive volume plus mix performance; sustained positive trailing performance with volume/mix-led growth in 8 of the last 10 quarters in North America and trailing 12-month category growth ~2%.
Negative Updates
China Diaper Disruption
Significant social-media-driven disruption in China diapers (largest incident they've faced), which produced a meaningful sellout/consumption impact: roughly a 50 basis point headwind in Q2; management referenced uncertainty in recovery and incorporated China weakness into outlook (guidance previously assumed ~100 bps for the year; management later discussed ~200 bps of second-half impact distributed across Q3/Q4).
Read all updates
Q2-2026 Updates
Positive
Negative
Sustained Volume + Mix Momentum
Delivered 10th consecutive quarter of positive volume plus mix performance; sustained positive trailing performance with volume/mix-led growth in 8 of the last 10 quarters in North America and trailing 12-month category growth ~2%.
Read all positive updates
Company Guidance
Kimberly‑Clark updated its 2026 outlook to reflect a $45 million U.S./Canada tariff refund and about $150 million of gross input‑cost headwinds in H2 (the company had previously cited $150–$170M if oil were ~$100/bbl), which management says will be largely offset by mitigating actions and productivity so that pricing net of cost inflation is roughly neutral for the full year; Q2 organic sales ran ~100 basis points below expectations, driven in part by a ~50‑bp China diaper sell‑out impact in Q2 (management had contemplated ~100 bps for the year) and North America retailer destocking, with North America shipments lagging consumption by ~170 bps in Q2 (shipments −1.4% vs consumption +0.3%) and ~200 bps for the first half. Despite the noise, the company delivered its 10th consecutive quarter of positive volume plus mix, industry‑leading gross productivity of 6.4%, adjusted operating profit and EPS that beat expectations (helped by the $45M refund), weighted‑share performance broadly stable, 1H pricing down ~50 bps overall but planned low‑single‑digit pricing actions in North America in H2, and reiterated confidence in the Kenvue transaction ($1.9B synergy target with integration planning running ahead; further 2027 detail to be provided as close approaches).Kimberly Clark Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
43
Neutral
Cash Flow
58
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.57B | 17.22B | 20.06B | 20.43B | 20.18B | 19.44B |
| Gross Profit | 6.08B | 6.13B | 7.18B | 7.03B | 6.22B | 5.99B |
| EBITDA | 3.19B | 3.30B | 3.98B | 3.07B | 3.38B | 3.25B |
| Net Income | 1.96B | 2.02B | 2.54B | 1.76B | 1.93B | 1.81B |
Balance Sheet | ||||||
| Total Assets | 18.55B | 17.23B | 16.55B | 17.34B | 17.97B | 17.84B |
| Cash, Cash Equivalents and Short-Term Investments | 956.00M | 688.00M | 1.02B | 1.09B | 427.00M | 270.00M |
| Total Debt | 6.52B | 7.30B | 7.92B | 8.11B | 8.55B | 8.70B |
| Total Liabilities | 16.66B | 15.57B | 15.57B | 16.28B | 17.27B | 17.10B |
| Stockholders Equity | 1.75B | 1.50B | 840.00M | 915.00M | 547.00M | 514.00M |
Cash Flow | ||||||
| Free Cash Flow | 2.56B | 1.64B | 2.51B | 2.78B | 1.86B | 1.72B |
| Operating Cash Flow | 3.33B | 2.78B | 3.23B | 3.54B | 2.73B | 2.73B |
| Investing Cash Flow | -3.44B | -951.00M | -100.00M | -418.00M | -785.00M | -1.06B |
| Financing Cash Flow | 820.00M | -2.18B | -3.17B | -2.37B | -1.76B | -1.70B |
Kimberly Clark Technical Analysis
Neutral
111.02
Price Trends
102.74
Negative
103.39
Negative
100.39
Negative
Market Momentum
-1.32
Negative
47.06
Neutral
72.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KMB, the sentiment is Neutral. The current price of 111.02 is above the 20-day moving average (MA) of 97.45, above the 50-day MA of 102.74, and above the 200-day MA of 100.39, indicating a neutral trend. The MACD of -1.32 indicates Negative momentum. The RSI at 47.06 is Neutral, neither overbought nor oversold. The STOCH value of 72.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for KMB.
Kimberly Clark Risk Analysis
Kimberly Clark disclosed 26 risk factors in its most recent earnings report. Kimberly Clark reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Kimberly Clark Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $355.83B | 22.67 | 29.84% | 2.80% | 3.26% | 1.15% | |
75 Outperform | $23.69B | 32.09 | 17.78% | 1.22% | 2.69% | 46.04% | |
70 Outperform | $135.41B | 21.70 | 37.05% | 3.56% | -17.45% | 8.84% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $71.73B | 35.36 | 631.14% | 2.33% | 5.24% | -29.04% | |
60 Neutral | $32.85B | 16.72 | 122.57% | 5.19% | -12.19% | -19.22% | |
57 Neutral | $10.20B | 17.52 | -1893.55% | 5.89% | -5.41% | -26.46% |
* Consumer Defensive Sector Average
KMB
Kimberly Clark
99.41
-14.67
-12.86%
CHD
Church & Dwight
102.63
17.35
20.35%
CLX
Clorox
84.97
-28.12
-24.86%
CL
Colgate-Palmolive
92.78
17.04
22.50%
PG
Procter & Gamble
156.53
13.32
9.30%
UL
Unilever
63.86
0.81
1.29%
Kimberly Clark Corporate Events
Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
Kimberly-Clark Advances Kenvue Notes Exchange and Acquisition
Positive
Oct 13, 2026
On October 13, 2026, Kimberly-Clark announced early tender results for its exchange offers to swap any and all outstanding Kenvue notes for up to $7 billion of new Kimberly-Clark notes and cash, alongside related consent solicitations to amend the...
Business Operations and StrategyExecutive/Board Changes
Kimberly-Clark Announces Departure of President and COO
Negative
Oct 1, 2026
Kimberly-Clark reported that on September 29, 2026, President and Chief Operating Officer Russell Torres notified the company of his decision to leave, with his departure effective November 2, 2026. The exit of such a senior operational leader may...
Business Operations and StrategyM&A TransactionsPrivate Placements and FinancingRegulatory Filings and Compliance
Kimberly-Clark Launches Kenvue Note Exchange and Consent
Positive
Sep 28, 2026
On November 2, 2025, Kimberly-Clark agreed to acquire Kenvue through a two-step merger structure that will ultimately make Kenvue a wholly owned subsidiary, and on September 28, 2026, it launched exchange offers for any and all outstanding Kenvue ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.